K

Kevin McBride

About

Detail

Senior Accounting Leader / CPA | Controller-Level Impact | Accounting Infrastructure Modernization | Global Financial Consolidations & Operational Excellence
Philadelphia, Pennsylvania, United States

Timeline


work
Job

Résumé


Jobs verified_user 0% verified
  • Spark Therapeutics Inc
    Senior Director, Accounting and Controlling
    Spark Therapeutics Inc
    Oct 2024 - Oct 2025 (1 year 1 month)
    • Led enterprise accounting operations for a biotechnology organization supporting ~700 employees, overseeing financial reporting, accounting operations, consolidations, and compliance for various business units and international subsidiaries.
    • Directed a 7-person accounting leadership team including Tax Director, Payroll Director, Accounting Directors, and finance systems leadership responsible for end-to-end accounting operations.
    • Managed annual operating expenses of ~$500M and reporting for an organization with ~$1B in assets and ~$70M in annual revenue.
    • Oversaw transition of accounting activities to a shared services operating model, aligning Spark accounting processes with Roche global finance systems.
    • Mainta
  • Spark Therapeutics Inc
    Director, Financial Reporting
    Spark Therapeutics Inc
    Mar 2022 - Sep 2024 (2 years 7 months)
    • Managed preparation and review of consolidated financial statements including balance sheet, income statement, cash flow statement, and equity reporting submitted to Roche corporate finance.
    • Reduced month-end close cycle from 15 days to 3 days by redesigning close procedures, standardizing processes, and reducing manual accounting workflows.
    • Partnered with Roche corporate finance to align reporting structures, financial controls, and accounting policies following Spark’s transition from public company reporting to Roche’s global private company framework.
    • Oversaw financial reporting for international operations including 2 European subsidiaries, coordinating closely with international finance teams and external provid
  • Spark Therapeutics Inc
    Financial Reporting Lead
    Spark Therapeutics Inc
    Dec 2019 - Feb 2022 (2 years 3 months)
    • Led financial reporting during Spark’s transition from a publicly traded company to Roche ownership, ensuring continuity of reporting and alignment with Roche reporting timelines.
    • Prepared and reviewed consolidated financial statements and reporting packages for corporate submission to Roche finance leadership.
    • Served as primary point of contact for auditors during quarterly and annual audit cycles.
    • Supported integration of Spark’s accounting operations into Roche global finance structure following the acquisition.
  • Spark Therapeutics Inc
    Accounting Lead
    Spark Therapeutics Inc
    Sep 2016 - Nov 2019 (3 years 3 months)
    • Prepared and reviewed SEC filings including Forms 10-K and 10-Q, including financial statements, footnotes, and MD&A during Spark’s public company period.
    • Managed all equity accounting including RSUs, RSAs, ISOs, NQs, and ESPP programs prior to Roche acquisition.
    • Implemented a company-wide equity management platform, auditing historical grant and demographic data to ensure accurate financial reporting prior to go-live.
    • Oversaw general ledger operations, consolidations, and financial statement preparation for domestic and international entities; partnered with international subsidiaries to streamline reporting and improve monthly close accuracy/efficiency.
  • Qlik
    SEC Consolidation and Reporting Analyst
    Qlik
    Aug 2012 - Sep 2016 (4 years 2 months)
    • Managed monthly global consolidation of financial results for ~20 international entities, coordinating reporting submissions from global finance teams and ensuring accurate, timely consolidated financial statements.
    • Prepared and supported SEC filings including Forms 10-K and 10-Q, drafting consolidated financial statements, footnotes, MD&A, and XBRL tagging while ensuring compliance with US GAAP and regulatory requirements.
    • Reviewed quarterly reporting packages from global subsidiaries, analyzing financial variances, validating accounting classifications, and improving the accuracy of consolidated financial reporting.
    • Maintained accounting for the parent holding company, overseeing journal entries, accruals, and finan
  • AmerisourceBergen
    Financial Reporting Analyst
    AmerisourceBergen
    Mar 2010 - Jul 2012 (2 years 5 months)
    • Prepared journal entries and reconciliations supporting corporate financial reporting operations for a Fortune 10 pharmaceutical distributor, ensuring accuracy and compliance with internal reporting standards.
    • Supported preparation of SEC filings and financial statement disclosures, including share-based compensation and receivables securitization program reporting.
    • Managed accounting for employee equity compensation programs and ~1.6K corporate leases, ensuring accurate expense recognition and disclosure of future lease obligations.
  • KPMG US
    Audit Associate
    KPMG US
    Sep 2007 - Sep 2009 (2 years 1 month)
    • Performed financial statement audits for financial services clients including banks and investment firms, reviewing SEC filings and disclosures to ensure compliance with US GAAP and regulatory requirements.
    • Supported complex audit engagements including restatement reviews and large-scale securities confirmations, while mentoring junior auditors and coordinating deliverables under tight reporting deadlines.
Education verified_user 0% verified
  • La Salle University
    La Salle University
    La Salle University